|
[1] United Network for Organ Sharing[DB/OL].http://www.unos.org/.
|
|
[2]KASAHARA M,UMESHITA K,INOMATA Y,et al.Long-term outcomes of pediatric living donor liver transplantation in Japan:an analysis of more than 2200 cases listed in the registry of the Japanese Liver Transplantation Society[J].Am J Transplant,2013,13(7):1830-1839.
|
|
[3]KELLY DA,BUCUVALAS JC,ALONSO EM,et al.Long-term medical management of the pediatric patient after liver transplantation:2013 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation[J].Liver Transpl,2013,19(8):798-825.
|
|
[4]SQUIRES RH,NG V,ROMERO R,et al.Evaluation of the pediatric patient for liver transplantation:2014 practice guideline by the American Association for the Study of Liver Diseases,American Society of Transplantation and the North American Society for Pediatric Gastroenterology,Hepatology and Nutrition[J].Hepatology,2014,60(1):362-398.
|
|
[5] GRADE working group[DB/OL].http://www.gradeworkinggroup.org/index.htm.
|
|
[6] China Liver Transplant Registry.Scientific Report on Liver Transplantation in Children in 2011[EB/OL].http://www.cltr.org/.(in Chinese)中国肝移植注册.2011年儿童肝移植科学报告[EB/OL].http://www.cltr.org/.
|
|
[7]FAGIUOLI S,DAINA E,D'ANTIGA L,et al.Monogenic diseases that can be cured by liver transplantation[J].J Hepatol,2013,59(3):595-612.
|
|
[8] KERKAR N.Liver transplantation:a pediatric perspective[M]//AH-MAD J,FRIEDMAN SL,DANCYGIER H.Mount Sinai expert guides:Hepatology.Oxford:John Wiley&Sons,Ltd,2014:394-403.
|
|
[9]AHMED A,KEEFFE EB.Current indications and contraindications for liver transplantation[J].Clin Liver Dis,2007,11(2):227-247.
|
|
[10] Organ Procurement and Transplantation Network[DB/OL].http://optn.transplant.hrsa.gov/.
|
|
[11]ARGUEDAS MR,ABRAMS GA,KROWKA MJ,et al.Prospective evaluation of outcomes and predictors of mortality in patients with hepatopulmonary syndrome undergoing liver transplantation[J].Hepatology,2003,37(1):192-197.
|
|
[12]CONDINO AA,LVY DD,O'CONNOR JA,et al.Portopulmonary hypertension in pediatric patients[J].J Pediatr,2005,147(1):20-26.
|
|
[13] KROWKA MJ,SWANSON KL,FRANTZ RP,et al.Portopulmonary hypertension:results from a 10-year screening algorithm[J].Hepatology,2006,44(6):1502-1510.
|
|
[14]MILLER MR,SOKOL RJ,NARKEWICZ MR,et al.Pulmonary function in individuals who underwent liver transplantation:from the US cystic brosis foundation registry[J].Liver Transpl,2012,18(5):585-593.
|
|
[15] SCHWARTZ GJ,MU OZ A,SCHNEIDER MF,et al.New equations to estimate GFR in children with CKD[J].J Am Soc Nephrol,2009,20(3):629-637.
|
|
[16] FINNEY H,NEWMAN DJ,THAKKAR H,et al.Reference ranges for plasma cystatin C and creatinine measurements in premature infants,neonates,and older children[J].Arch Dis Child,2000,82(1):71-75.
|
|
[17]SAMYN M,CHEESEMAN P,BEVIS L,et al.Cystatin C,an easy and reliable marker for assessment of renal dysfunction in children with liver disease and after liver transplantation[J].Liver Transpl,2005,11(3):344-349.
|
|
[18] SULTAN MI,LEON CD,BIANK VF.Role of nutrition in pediatric chronic liver disease[J].Nutr Clin Pract,2011,26(4):401-408.
|
|
[19] SATHE MN,PATEL AS.Update in pediatrics:focus on fat-soluble vitamins[J].Nutr Clin Pract,2010,25(4):340-346.
|
|
[20] SULLIVAN JS,SUNDARAM SS,PAN Z,et al.Parenteral nutrition supplementation in biliary atresia patients listed for liver transplantation[J].Liver Transpl,2012,18(1):120-128.
|
|
[21]KALLER T,SCHULZ KH,SANDER K,et al.Cognitive abilities in children after liver transplantation[J].Transplantation,2005,79(9):1252-1256.
|
|
[22]SORENSEN LG,NEIGHBORS K,MARTZ K,et al.Cognitive and academic outcomes after pediatric liver transplantation:Functional Outcomes Group(FOG)results[J].Am J Transpl,2011,11(2):303-311.
|
|
[23] LYKAVIERIS P,CHARDOT C,SOKHN M,et al.Outcome in adulthood of biliary atresia:a study of 63 patients who survived for over 20 years with their native liver[J].Hepatology,2005,41(2):366-371.
|
|
[24]SEDA NETO J,FEIER FH,BIERRENBACH AL,et al.Impact of Kasai portoenterostomy on liver transplantation outcomes:a retrospective cohort study of 347 children with biliary atresia[J].Liver Transpl,2015,21(7):922-927.
|
|
[25] SOKOL RJ,SHEPHERD RW,SUPERINA R,et al.Screening and outcomes in biliary atresia:summary of a National Institues of Health wordshop[J].Hepatology,2007,46(2):566-581.
|
|
[26] EMERICK KM,RAND EB,GOLDMUNTZ E,et al.Features of Alagille syndrome in 92 patients:frequency and relation to prognosis[J].Hepatology,1999,29(3):822-829.
|
|
[27]KASAHARA M,SAKAMOTO S,HORIKAWA R,et al.Living donor liver transplantation for pediatric patients with metabolic disorders:the Japanese multicenter registry[J].Pediatr Transplant,2014,18(1):6-15.
|
|
[28]MAZARIEGOS G,SHNEIDER B,BURTON B,et al.Liver transplantation for pediatric metabolic disease[J].Mol Genet Metab,2014,111(4):418-427.
|
|
[29]LIU E,MACKENZIE T,DOBYNS EL,et al.Characterization of acute liver failure and development of a continuous risk of death staging system in children[J].J Hepatol,2006,44(1):134-141.
|
|
[30]LU BR,ZHANG S,NARKEWICZ MR,et al.Evaluation of the liver injury unit scoring system to predict survival in a multinational study of pediatric acute liver failure[J].J Pediatr,2013,162(5):1010-1016.
|
|
[31] ISMAIL H,BRONISZCZAK D,KALICISKI P,et al.Liver transplantation in children with hepatocellular carcinoma.Do Milan criteria apply to pediatric patients?[J].Pediatr Transplant,2009,13(6):682-692.
|
|
[32] ROMANO F,STROPPA P,BRAVI M,et al.Favorable outcome of primary liver transplantation in children with cirrhosis and hepatocellular carcinoma[J].Pediatr Transplant,2011,15(6):573-579.
|
|
[33]EGAWA H,OIKE F,BUHLER L,et al.Impact of recipient age on outcome of ABO-incompatible living-donor liver transplantation[J].Transplantation,2004,77(3):403-411.
|
|
[34]OKADA N,SANADA Y,HIRATA Y,et al.The impact of rituximab in ABO-incompatible pediatric living donor liver transplantation:the experience of a single center[J].Pediatr Transplant,2015,19(3):279-286.
|
|
[35]SCHUKFEH N,LENZ V,METZELDER ML,et al.First case studies of successful ABO-incompatible living-related liver transplantation in infants in Germany[J].Eur J Pediatr Surg,2015,25(1):77-81.
|
|
[36] POPESCU I,HABIB N,DIMA S,et al.Domino liver transplantation using a graft from a donor with familial hypercholesterolemia:seven-yr follow-up[J].Clin Transplant,2009,23(4):565-570.
|
|
[37]LIU C,NIU DM,LOONG CC,et al.Domino liver graft from a patient with homozygous familial hypercholesterolemia[J].Pediatr Transplant,2010,14(3):e30-e33.
|
|
[38] POPESCU I,DIMA SO.Domino liver transplantation:how far can we push the paradigm?[J].Liver Transpl,2012,18(1):22-28.
|
|
[39]RELA M,MUIESAN P,ANDREANI P,et al.Auxiliary liver transplantation for metabolic diseases[J].Transplant Proc,1997,29(1-2):444-445.
|
|
[40] ROSENTHAL P,ROBERTS JP,ASCHER NL,et al.Auxiliary liver transplant in fulminant failure[J].Pediatrics,1997,100(2):e10.
|
|
[41] de GOYET JV,ROGIERS X,OTTE JB.Split-liver transplantation for the pediatric and adult recipient[M]//BUSUTTIL RW,KLINTMALM GK.Transplantation of the Liver.New York:Saunders,2005:609-627.
|
|
[42]ACKERMANN O,BRANCHEREAU S,FRANCHI-ABELLA S,et al.The long-term outcome of hepatic artery thrombosis after liver transplantation in children:role of urgent revascularization[J].Am JTransplant,2012,12(6):1496-1503.
|
|
[43]GU L,FANG H,LI F,et al.Impact of hepatic arterial hemodynamics in predicting early hepatic arterial thrombosis in pediatric recipients younger than three yr after living donor liver transplantation[J].Pediatr Transplant,2015,19(3):273-278.
|
|
[44]GU LH,FANG H,LI FH,et al.Prediction of early hepatic artery thrombosis by intraoperative color Doppler ultrasound in pediatric segmental liver transplantation[J].Clin Transplant,2012,26(4):571-576.
|
|
[45]WARNAAR N,POLAK WG,de JONG KP,et al.Long-term results of urgent revascularization for hepatic artery thrombosis after pediatric liver transplantation[J].Liver Transpl,2010,16(7):847-855.
|
|
[46]RODRGUEZ-CASTRO KI,PORTE RJ,NADAL E,et al.Management of nonneoplastic portal vein thrombosis in the setting of liver transplantation:a systematic review[J].Transplantation,2012,94(11):1145-1153.
|
|
[47]JENSEN MK,CAMPBELL KM,ALONSO MH,et al.Management and long-term consequences of portal vein thrombosis after liver transplantation in children[J].Liver Transpl,2013,19(3):315-321.
|
|
[48]TAKATSUKI M,CHEN CL,CHEN YS,et al.Systemic thrombolytic therapy for late-onset portal vein thrombosis after living-donor liver transplantation[J].Transplantation,2004,77(7):1014-1018.
|
|
[49]SOMMOVILLA J,DOYLE MM,VACHHARAJANI N,et al.Hepatic venous outflow obstruction in pediatric liver transplantation:technical considerations in prevention,diagnosis,and management[J].Pediatr Transplant,2014,18(5):497-502.
|
|
[50]KO GY,SUNG KB,YOON HK,et al.Early posttransplant hepatic venous outflow obstruction:long-term efficacy of primary stent placement[J].Liver Transpl,2008,14(10):1505-1511.
|
|
[51]DECHNE A,KODDE C,KATHEMANN S,et al.Endoscopic treatment of pediatric post-transplant biliary complications is safe and effective[J].Dig Endosc,2015,27(4):505-511.
|
|
[52]LAURENCE JM,SAPISOCHIN G,DEANGELIS M,et al.Biliary complications in pediatric liver transplantation:incidence and management over a decade[J].Liver Transpl,2015,21(8):1082-1090.
|
|
[53] SHARMA S,GURAKAR A,JABBOUR N.Biliary strictures following liver transplantation:past,present and preventive strategies[J].Liver Transpl,2008,14(6):759-769.
|
|
[54]TANAKA H,FUKUDA A,SHIGETA T,et al.Biliary reconstruction in pediatric live donor liver transplantation:duct-to-duct or Rouxen-Y hepaticojejunostomy[J].J Pediatr Surg,2010,45(8):1668-1675.
|
|
[55] HUMAR A,SNYDMAN D;AST Infectious Diseases Community of Practice.Cytomegalovirus in solid organ transplant recipients[J].Am J Transplant,2009,9(Suppl 4):s78-s86.
|
|
[56] LJUNGMAN P,GRIFFITHS P,PAYA C.Definitions of cytomegalovirus infection and disease in transplant recipients[J].Clin Infect Dis,2002,34(8):1094-1097.
|
|
[57]MADAN RP,CAMPBELL AL,SHUST GF,et al.A hybrid strategy for the prevention of cytomegalovirus-related complications in pediatric liver transplantation recipients[J].Transplantation,2009,87(9):1318-1324.
|
|
[58]DANZIGER-ISAKOV L,BUCAVALAS J.Current prevention strategies against cytomegalovirus in the studies in pediatric liver transplantation(SPLIT)centers[J].Am J Transplant,2014,14(8):1908-1911.
|
|
[59]GREEN M,MICHAELS MG.Epstein-Barr virus infection and posttransplant lymphoproliferative disorder[J].Am J Transplant,2013,13(Suppl 3):41-54.
|
|
[60]ALLEN UD,PREIKSAITIS JK;AST Infectious Diseases Community of Practice.Epstein-Barr virus and posttransplant lymphoproliferative disorder in solid organ transplantation[J].Am J Transplant,2013,13(Suppl 4):107-120.
|
|
[61]NARKEWICZ MR,GREEN M,DUNN S,et al.Decreasing incidence of symptomatic Epstein-Barr virus disease and posttransplant lymphoproliferative disorder in pediatric liver transplant recipients:report of the studies of pediatric liver transplantation experience[J].Liver Transpl,2013,19(7):730-740.
|
|
[62]RESHEF R,VARDHANABHUTI S,LUSKIN MR,et al.Reduction of immunosuppression as initial therapy for posttransplantation lymphoproliferative disorder[J].Am J Transplant,2011,11(2):336-347.
|
|
[63]XI ZF,XIA Q,ZHANG JJ,et al.De novo hepatitis B virus infection from anti-HBc-positive donors in pediatric living donor liver transplantation[J].J Dig Dis,2013,14(8):439-445.
|
|
[64]RAO W,XIE M,YANG T,et al.Risk factors for de novo hepatitis B infection in pediatric living donor liver transplantation[J].World J Gastroenterol,2014,20(36):13159-13166.
|
|
[65]JONAS MM,BLOCK JM,HABER BA,et al.Treatment of children with chronic hepatitis B virus infection in the United States:patient selection and therapeutic options[J].Hepatology,2010,52(6):2192-2205.
|
|
[66]ALLERN U,GREEN M.Prevention and treatment of infectious complications after solid organ transplantation in children[J].Pediatr Clin North Am,2010,57(2):459-479.
|
|
[67]KELLY D,JARA P,RODECK B,et al.Tacrolimus and steroids versus ciclosporin microemulsion,steroids,and azathioprine in children undergoing liver transplantation:randomized European multicentre trial[J].Lancet,2004,364(9439):1054-1061.
|
|
[68] NH VL,FECTEAU A,SHEPHERD R,et al.Outcomes of 5-year survivors of pediatric liver transplantation:report on 461 children from a north americanmulticenter registry[J].Pediatrics,2008,122(6):e1128-e1135.
|
|
[69]TAYLOR AL,GIBBS P,SUDHINDRAN S,et al.Monitoring systemic donor lymphocyte macrochimerism to aid the diagnosis of graft-versus-host disease afterliver transplantation[J].Transplantation,2004,77(3):441-446.
|
|
[70]XUE F,HAN L,CHEN Y,et al.CYP3A5 genotypes affect tacrolimus pharmacokinetics and infectious complications in Chinese pediatric liver transplant patients[J].Pediatr Transplant,2014,18(2):166-176.
|
|
[71] CHEN YK,HAN LZ,XUE F,et al.Personalized tacrolimus dose requirement by CYP3A5 but not ABCB1 or ACE genotyping in both recipient and donor after pediatric liver transplantation[J].PLoSOne,2014,9(10):e109464.
|
|
[72]KELLY D.Safety and efficacy of tacrolimus in pediatric liver recipients[J].Pediatr Transplant,2011,15(1):19-24.
|
|
[73] GRAS JM,GERKENS S,BEGUIN C,et al.Steroid-free,tacrolimus-basiliximab immunosuppression in pediatric liver transplantation:clinical and pharmacoeconomic study in 50 children[J].Liver Transpl,2008,14(4):469-477.
|
|
[74]TURNER AP,KNECHTLE SJ.Induction immunosuppression in liver transplantation:a review[J].Transpl Int,2013,26(7):673-683.
|
|
[75] FENG S,EKONG UD,LOBRITTO SJ,et al.Complete immunosuppression withdrawal and subsequent allograft function among pediatric recipients of parental living donor liver transplants[J].JA-MA,2012,307(3):283-293.
|
|
[76]KOSHIBA T,LI Y,TAKEMURA M,et al.Clinical,immunological,and pathological aspects of operational tolerance after pediatric living---donor liver transplantation[J].Transpl Immunol,2007,17(2):94-97.
|
|
[77]CAMPBELL K,NG V,MARTIN S,et al.SPLIT Renal Function Working Group.Glomerular filtration rate following pediatric liver transplantation-the SPLIT experience[J].Am J Transplant,2010,10(12):2673-2682.
|
|
[78]ARORA-GUPTA N,DAVIES P,MCKIERNAN P,et al.The effect of long-term calcineurin inhibitor therapy on renal function in children after liver transplantation[J].Pediatr Transplant,2004,8(2):145-150.
|
|
[79]MCLIN VA,ANAND R,DANIELS SR,et al.Blood pressure elevation in long-term survivors of pediatric liver transplantation[J].Am J Transplant,2012,12(1):183-190.
|
|
[80] HATHOUT E,ALONSO E,ANAN R,et al.Posttransplant diabetes mellitus in pediatric liver transplantation[J].Pediatr Transplant,2009,13(5):599-605.
|
|
[81]KUO HT,LAU C,SAMPAIO MS,et al.Pretransplant risk factors for new-onset diabetes mellitus after transplant in pediatric liver transplant recipients[J].Liver Transpl,2010,16(11):1249-1256.
|
|
[82]MCDIARMID SV,GORNBEIN JA,DESILVA PJ,et al.Factors affecting growth after pediatric liver transplantation[J].Transplantation,1999,67(3):404-411.
|
|
[83] ALONSO EM,SHEPHERD R,MARTZ KL,et al.Linear growth patterns in prepubertal children following liver transplantation[J].Am JTransplant,2009,9(6):1389-1397.
|
|
[84]BARTOSH SM,THOMAS SE,SUTTON MM,et al.Linear growth after pediatric liver transplantation[J].J Pediatr,1999,135(5):624-631.
|
|
[85] GILMOUR S,ADKINS R,LIDDELL GA,et al.Assessment of psychoeducational outcomes after pediatric liver transplant[J].Am J Transplant,2009,9(2):294-300.
|
|
[86] MINTZER LL,STUBER ML,SEACORD D,et al.Traumatic stress symptoms in adolescent organ transplant recipients[J].Pediatrics,2005,115(6):1640-1644.
|
|
[87] DANZINGER-ISAKOV L,KUMAR D;AST Infectious Diseases Community of Practice.Guidelines for vaccination of solid organ transplant candidates and recipients[J].Am J Transplant,2009,9(Suppl 4):s258-s262.
|
|
[88] RUBIN LG,LEVIN MJ,LJUNGMAN P,et al.2013 IDSA clinica practice guideline for vaccination of the immunocompromised host[J].Clin Infect Dis,2014,58(3):309-318.
|
|
[89] de BLESER L,DOBBELS F,BERBEN L,et al.The spectrum o non-adherence with medication in heart,liver,and lung transplan patients assessed in various ways[J].Transpl Int,2011,24(9):882-891.
|
DownLoad: